Effects of barium, furosemide, ouabaine and 4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS) on ionophoretically-induced changes in extracellular potassium concentration in hippocampal slices from rats and from patients with epilepsy

Glial cells limit local K +-accumulation by K +-uptake through different mechanisms, sensitive to Ba 2+, ouabaine, furosemide, or DIDS. Since the relative contribution of these mechanisms has not yet been determined, we studied the effects of bath-applied barium (2 mM), ouabaine (9 μM), furosemide (...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain research 2002-01, Vol.925 (1), p.18-27
Hauptverfasser: Jauch, Regina, Windmüller, Olaf, Lehmann, Thomas-Nicolas, Heinemann, Uwe, Gabriel, Siegrun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 27
container_issue 1
container_start_page 18
container_title Brain research
container_volume 925
creator Jauch, Regina
Windmüller, Olaf
Lehmann, Thomas-Nicolas
Heinemann, Uwe
Gabriel, Siegrun
description Glial cells limit local K +-accumulation by K +-uptake through different mechanisms, sensitive to Ba 2+, ouabaine, furosemide, or DIDS. Since the relative contribution of these mechanisms has not yet been determined, we studied the effects of bath-applied barium (2 mM), ouabaine (9 μM), furosemide (2 mM), and DIDS (1 mM) on ionophoretically-induced rises in [K +] o in the pyramidal layer of area CA1 from normal rat slices, in the presence of glutamate receptor (Glu-R) antagonists. We also investigated the effect of barium on ionophoretically-induced tetrapropylammonium (TPA +)-signals in order to test for barium-induced changes of the extracellular space. Finally, we repeated the barium experiment on slices from human non-sclerotic and sclerotic hippocampal specimens to assess a reduced glial capability for barium-sensitive K +-uptake in sclerotic tissue from epilepsy patients. In normal rat slices barium augmented ionophoretically-induced rises in [K +] o by ∼120%, also in the presence of tetrodotoxin (TTX) (by ∼150%), but did not significantly affect the TPA +-signal. Ouabaine also augmented the K +-signal, but only by 27%. Furosemide and DIDS had negligible effects. In slices from sclerotic human hippocampus an augmentation of the K +-signal by barium was absent. Thus barium augments ionophoretically-induced K +-signals to a similar extent as previously shown for stimulus-induced signals. We suggest that glial barium-sensitive K +-buffer mechanisms reduce fast local rises of [K +] o by at least 50%. This capability of glial cells is extremely reduced in area CA1 of slices from human sclerotic hippocampal specimens.
doi_str_mv 10.1016/S0006-8993(01)03254-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18348463</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006899301032541</els_id><sourcerecordid>18348463</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-fa9ea8d04fa61ed13d1baa5e09ad965a81c3b986edb9b90a2f3f96618559a96f3</originalsourceid><addsrcrecordid>eNqFkk1uFDEQhVsIRIbAEUDegBJpGuz-9wqhJECkSCwCa6vaLjOFuu3G7gZmx5k4EodgjedHZMnKKtX3yuX3nGVPBX8puGhe3XLOm7yTsjzj4pyXRV3l4l62El1b5E1R8fvZ6h9ykj2K8Usqy1Lyh9mJEG1dd7JdZX-urEU9R-Yt6yHQMq6ZXYKPOJLBNfML9EAOGTjDqnX1--ev3BBFP2_I6y04mH2caejRYV6si0M_LoP1jjQDTYadXV5f3p4z7xh556eNDziThmHY5uTMotEwvQH3GSMjx_DHHEDjMCwDBDb5GWJMazHtnUaXejPtJjm2oWnyGsYJBhYH0klugx9ZIuJ-3X01JT7JIvtO84bhRANOcfs4e2BhiPjkeJ5mn95efbx4n998eHd98eYm11VbzbkFidAZXlloBBpRGtED1MglGNnU0Ald9rJr0PSylxwKW1rZNKKrawmyseVp9uIwdwr-64JxViPF3ePAoV-iEl1ZdVVTJrA-gDp5HwNaNQUaIWyV4GoXuNoHrnZpKi7UPnAlku7Z8YKlH9HcqY4JJ-D5EYCYPLcBnKZ4x5VV3cq2S9zrA4fJjm-EQUWdjEvhUEgfRBlP_1nlLy4C0O0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18348463</pqid></control><display><type>article</type><title>Effects of barium, furosemide, ouabaine and 4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS) on ionophoretically-induced changes in extracellular potassium concentration in hippocampal slices from rats and from patients with epilepsy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Jauch, Regina ; Windmüller, Olaf ; Lehmann, Thomas-Nicolas ; Heinemann, Uwe ; Gabriel, Siegrun</creator><creatorcontrib>Jauch, Regina ; Windmüller, Olaf ; Lehmann, Thomas-Nicolas ; Heinemann, Uwe ; Gabriel, Siegrun</creatorcontrib><description>Glial cells limit local K +-accumulation by K +-uptake through different mechanisms, sensitive to Ba 2+, ouabaine, furosemide, or DIDS. Since the relative contribution of these mechanisms has not yet been determined, we studied the effects of bath-applied barium (2 mM), ouabaine (9 μM), furosemide (2 mM), and DIDS (1 mM) on ionophoretically-induced rises in [K +] o in the pyramidal layer of area CA1 from normal rat slices, in the presence of glutamate receptor (Glu-R) antagonists. We also investigated the effect of barium on ionophoretically-induced tetrapropylammonium (TPA +)-signals in order to test for barium-induced changes of the extracellular space. Finally, we repeated the barium experiment on slices from human non-sclerotic and sclerotic hippocampal specimens to assess a reduced glial capability for barium-sensitive K +-uptake in sclerotic tissue from epilepsy patients. In normal rat slices barium augmented ionophoretically-induced rises in [K +] o by ∼120%, also in the presence of tetrodotoxin (TTX) (by ∼150%), but did not significantly affect the TPA +-signal. Ouabaine also augmented the K +-signal, but only by 27%. Furosemide and DIDS had negligible effects. In slices from sclerotic human hippocampus an augmentation of the K +-signal by barium was absent. Thus barium augments ionophoretically-induced K +-signals to a similar extent as previously shown for stimulus-induced signals. We suggest that glial barium-sensitive K +-buffer mechanisms reduce fast local rises of [K +] o by at least 50%. This capability of glial cells is extremely reduced in area CA1 of slices from human sclerotic hippocampal specimens.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/S0006-8993(01)03254-1</identifier><identifier>PMID: 11755897</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>London: Elsevier B.V</publisher><subject>2-Amino-5-phosphonovalerate - pharmacology ; 4,4'-Diisothiocyanatostilbene-2,2'-disulfonic acid ; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid - pharmacology ; Anesthetics, Local - pharmacology ; Animals ; Barium - pharmacology ; Biological and medical sciences ; Buffers ; Diuretics - pharmacology ; Enzyme Inhibitors - pharmacology ; Epilepsy ; Epilepsy - metabolism ; Epilepsy - pathology ; Excitatory Amino Acid Antagonists - pharmacology ; Extracellular Space - metabolism ; furosemide ; Furosemide - pharmacology ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; Hippocampus ; Hippocampus - drug effects ; Hippocampus - metabolism ; Hippocampus - pathology ; Human ; Humans ; In Vitro Techniques ; Iontophoresis ; Medical sciences ; Nervous system (semeiology, syndromes) ; Neurology ; Ouabain - pharmacology ; Potassium - metabolism ; Potassium buffering ; Quaternary Ammonium Compounds - pharmacokinetics ; Quinoxalines - pharmacology ; Rat ; Rats ; Rats, Wistar ; Sclerosis ; Tetrodotoxin - pharmacology</subject><ispartof>Brain research, 2002-01, Vol.925 (1), p.18-27</ispartof><rights>2002 Elsevier Science B.V.</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-fa9ea8d04fa61ed13d1baa5e09ad965a81c3b986edb9b90a2f3f96618559a96f3</citedby><cites>FETCH-LOGICAL-c474t-fa9ea8d04fa61ed13d1baa5e09ad965a81c3b986edb9b90a2f3f96618559a96f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006899301032541$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13457978$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11755897$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jauch, Regina</creatorcontrib><creatorcontrib>Windmüller, Olaf</creatorcontrib><creatorcontrib>Lehmann, Thomas-Nicolas</creatorcontrib><creatorcontrib>Heinemann, Uwe</creatorcontrib><creatorcontrib>Gabriel, Siegrun</creatorcontrib><title>Effects of barium, furosemide, ouabaine and 4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS) on ionophoretically-induced changes in extracellular potassium concentration in hippocampal slices from rats and from patients with epilepsy</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>Glial cells limit local K +-accumulation by K +-uptake through different mechanisms, sensitive to Ba 2+, ouabaine, furosemide, or DIDS. Since the relative contribution of these mechanisms has not yet been determined, we studied the effects of bath-applied barium (2 mM), ouabaine (9 μM), furosemide (2 mM), and DIDS (1 mM) on ionophoretically-induced rises in [K +] o in the pyramidal layer of area CA1 from normal rat slices, in the presence of glutamate receptor (Glu-R) antagonists. We also investigated the effect of barium on ionophoretically-induced tetrapropylammonium (TPA +)-signals in order to test for barium-induced changes of the extracellular space. Finally, we repeated the barium experiment on slices from human non-sclerotic and sclerotic hippocampal specimens to assess a reduced glial capability for barium-sensitive K +-uptake in sclerotic tissue from epilepsy patients. In normal rat slices barium augmented ionophoretically-induced rises in [K +] o by ∼120%, also in the presence of tetrodotoxin (TTX) (by ∼150%), but did not significantly affect the TPA +-signal. Ouabaine also augmented the K +-signal, but only by 27%. Furosemide and DIDS had negligible effects. In slices from sclerotic human hippocampus an augmentation of the K +-signal by barium was absent. Thus barium augments ionophoretically-induced K +-signals to a similar extent as previously shown for stimulus-induced signals. We suggest that glial barium-sensitive K +-buffer mechanisms reduce fast local rises of [K +] o by at least 50%. This capability of glial cells is extremely reduced in area CA1 of slices from human sclerotic hippocampal specimens.</description><subject>2-Amino-5-phosphonovalerate - pharmacology</subject><subject>4,4'-Diisothiocyanatostilbene-2,2'-disulfonic acid</subject><subject>4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid - pharmacology</subject><subject>Anesthetics, Local - pharmacology</subject><subject>Animals</subject><subject>Barium - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Buffers</subject><subject>Diuretics - pharmacology</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Epilepsy</subject><subject>Epilepsy - metabolism</subject><subject>Epilepsy - pathology</subject><subject>Excitatory Amino Acid Antagonists - pharmacology</subject><subject>Extracellular Space - metabolism</subject><subject>furosemide</subject><subject>Furosemide - pharmacology</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>Hippocampus</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - metabolism</subject><subject>Hippocampus - pathology</subject><subject>Human</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Iontophoresis</subject><subject>Medical sciences</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Ouabain - pharmacology</subject><subject>Potassium - metabolism</subject><subject>Potassium buffering</subject><subject>Quaternary Ammonium Compounds - pharmacokinetics</subject><subject>Quinoxalines - pharmacology</subject><subject>Rat</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Sclerosis</subject><subject>Tetrodotoxin - pharmacology</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkk1uFDEQhVsIRIbAEUDegBJpGuz-9wqhJECkSCwCa6vaLjOFuu3G7gZmx5k4EodgjedHZMnKKtX3yuX3nGVPBX8puGhe3XLOm7yTsjzj4pyXRV3l4l62El1b5E1R8fvZ6h9ykj2K8Usqy1Lyh9mJEG1dd7JdZX-urEU9R-Yt6yHQMq6ZXYKPOJLBNfML9EAOGTjDqnX1--ev3BBFP2_I6y04mH2caejRYV6si0M_LoP1jjQDTYadXV5f3p4z7xh556eNDziThmHY5uTMotEwvQH3GSMjx_DHHEDjMCwDBDb5GWJMazHtnUaXejPtJjm2oWnyGsYJBhYH0klugx9ZIuJ-3X01JT7JIvtO84bhRANOcfs4e2BhiPjkeJ5mn95efbx4n998eHd98eYm11VbzbkFidAZXlloBBpRGtED1MglGNnU0Ald9rJr0PSylxwKW1rZNKKrawmyseVp9uIwdwr-64JxViPF3ePAoV-iEl1ZdVVTJrA-gDp5HwNaNQUaIWyV4GoXuNoHrnZpKi7UPnAlku7Z8YKlH9HcqY4JJ-D5EYCYPLcBnKZ4x5VV3cq2S9zrA4fJjm-EQUWdjEvhUEgfRBlP_1nlLy4C0O0</recordid><startdate>20020118</startdate><enddate>20020118</enddate><creator>Jauch, Regina</creator><creator>Windmüller, Olaf</creator><creator>Lehmann, Thomas-Nicolas</creator><creator>Heinemann, Uwe</creator><creator>Gabriel, Siegrun</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>20020118</creationdate><title>Effects of barium, furosemide, ouabaine and 4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS) on ionophoretically-induced changes in extracellular potassium concentration in hippocampal slices from rats and from patients with epilepsy</title><author>Jauch, Regina ; Windmüller, Olaf ; Lehmann, Thomas-Nicolas ; Heinemann, Uwe ; Gabriel, Siegrun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-fa9ea8d04fa61ed13d1baa5e09ad965a81c3b986edb9b90a2f3f96618559a96f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>2-Amino-5-phosphonovalerate - pharmacology</topic><topic>4,4'-Diisothiocyanatostilbene-2,2'-disulfonic acid</topic><topic>4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid - pharmacology</topic><topic>Anesthetics, Local - pharmacology</topic><topic>Animals</topic><topic>Barium - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Buffers</topic><topic>Diuretics - pharmacology</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Epilepsy</topic><topic>Epilepsy - metabolism</topic><topic>Epilepsy - pathology</topic><topic>Excitatory Amino Acid Antagonists - pharmacology</topic><topic>Extracellular Space - metabolism</topic><topic>furosemide</topic><topic>Furosemide - pharmacology</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>Hippocampus</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - metabolism</topic><topic>Hippocampus - pathology</topic><topic>Human</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Iontophoresis</topic><topic>Medical sciences</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Ouabain - pharmacology</topic><topic>Potassium - metabolism</topic><topic>Potassium buffering</topic><topic>Quaternary Ammonium Compounds - pharmacokinetics</topic><topic>Quinoxalines - pharmacology</topic><topic>Rat</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Sclerosis</topic><topic>Tetrodotoxin - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jauch, Regina</creatorcontrib><creatorcontrib>Windmüller, Olaf</creatorcontrib><creatorcontrib>Lehmann, Thomas-Nicolas</creatorcontrib><creatorcontrib>Heinemann, Uwe</creatorcontrib><creatorcontrib>Gabriel, Siegrun</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jauch, Regina</au><au>Windmüller, Olaf</au><au>Lehmann, Thomas-Nicolas</au><au>Heinemann, Uwe</au><au>Gabriel, Siegrun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of barium, furosemide, ouabaine and 4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS) on ionophoretically-induced changes in extracellular potassium concentration in hippocampal slices from rats and from patients with epilepsy</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>2002-01-18</date><risdate>2002</risdate><volume>925</volume><issue>1</issue><spage>18</spage><epage>27</epage><pages>18-27</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>Glial cells limit local K +-accumulation by K +-uptake through different mechanisms, sensitive to Ba 2+, ouabaine, furosemide, or DIDS. Since the relative contribution of these mechanisms has not yet been determined, we studied the effects of bath-applied barium (2 mM), ouabaine (9 μM), furosemide (2 mM), and DIDS (1 mM) on ionophoretically-induced rises in [K +] o in the pyramidal layer of area CA1 from normal rat slices, in the presence of glutamate receptor (Glu-R) antagonists. We also investigated the effect of barium on ionophoretically-induced tetrapropylammonium (TPA +)-signals in order to test for barium-induced changes of the extracellular space. Finally, we repeated the barium experiment on slices from human non-sclerotic and sclerotic hippocampal specimens to assess a reduced glial capability for barium-sensitive K +-uptake in sclerotic tissue from epilepsy patients. In normal rat slices barium augmented ionophoretically-induced rises in [K +] o by ∼120%, also in the presence of tetrodotoxin (TTX) (by ∼150%), but did not significantly affect the TPA +-signal. Ouabaine also augmented the K +-signal, but only by 27%. Furosemide and DIDS had negligible effects. In slices from sclerotic human hippocampus an augmentation of the K +-signal by barium was absent. Thus barium augments ionophoretically-induced K +-signals to a similar extent as previously shown for stimulus-induced signals. We suggest that glial barium-sensitive K +-buffer mechanisms reduce fast local rises of [K +] o by at least 50%. This capability of glial cells is extremely reduced in area CA1 of slices from human sclerotic hippocampal specimens.</abstract><cop>London</cop><cop>Amsterdam</cop><cop>New York, NY</cop><pub>Elsevier B.V</pub><pmid>11755897</pmid><doi>10.1016/S0006-8993(01)03254-1</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-8993
ispartof Brain research, 2002-01, Vol.925 (1), p.18-27
issn 0006-8993
1872-6240
language eng
recordid cdi_proquest_miscellaneous_18348463
source MEDLINE; Elsevier ScienceDirect Journals
subjects 2-Amino-5-phosphonovalerate - pharmacology
4,4'-Diisothiocyanatostilbene-2,2'-disulfonic acid
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid - pharmacology
Anesthetics, Local - pharmacology
Animals
Barium - pharmacology
Biological and medical sciences
Buffers
Diuretics - pharmacology
Enzyme Inhibitors - pharmacology
Epilepsy
Epilepsy - metabolism
Epilepsy - pathology
Excitatory Amino Acid Antagonists - pharmacology
Extracellular Space - metabolism
furosemide
Furosemide - pharmacology
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Hippocampus
Hippocampus - drug effects
Hippocampus - metabolism
Hippocampus - pathology
Human
Humans
In Vitro Techniques
Iontophoresis
Medical sciences
Nervous system (semeiology, syndromes)
Neurology
Ouabain - pharmacology
Potassium - metabolism
Potassium buffering
Quaternary Ammonium Compounds - pharmacokinetics
Quinoxalines - pharmacology
Rat
Rats
Rats, Wistar
Sclerosis
Tetrodotoxin - pharmacology
title Effects of barium, furosemide, ouabaine and 4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS) on ionophoretically-induced changes in extracellular potassium concentration in hippocampal slices from rats and from patients with epilepsy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T05%3A51%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20barium,%20furosemide,%20ouabaine%20and%204,4%E2%80%B2-diisothiocyanatostilbene-2,2%E2%80%B2-disulfonic%20acid%20(DIDS)%20on%20ionophoretically-induced%20changes%20in%20extracellular%20potassium%20concentration%20in%20hippocampal%20slices%20from%20rats%20and%20from%20patients%20with%20epilepsy&rft.jtitle=Brain%20research&rft.au=Jauch,%20Regina&rft.date=2002-01-18&rft.volume=925&rft.issue=1&rft.spage=18&rft.epage=27&rft.pages=18-27&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/S0006-8993(01)03254-1&rft_dat=%3Cproquest_cross%3E18348463%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18348463&rft_id=info:pmid/11755897&rft_els_id=S0006899301032541&rfr_iscdi=true